162 related articles for article (PubMed ID: 31953433)
21. Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy.
Limaye V; Bundell C; Hollingsworth P; Rojana-Udomsart A; Mastaglia F; Blumbergs P; Lester S
Muscle Nerve; 2015 Aug; 52(2):196-203. PubMed ID: 25521389
[TBL] [Abstract][Full Text] [Related]
22. Anti-HMGCR antibodies in systemic sclerosis.
Hudson M; Luck Y; Stephenson M; Choi MY; Wang M; Baron M; Fritzler MJ;
Medicine (Baltimore); 2016 Nov; 95(44):e5280. PubMed ID: 27858897
[TBL] [Abstract][Full Text] [Related]
23. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China.
Jiao Y; Cai S; Lin J; Zhu W; Xi J; Li J; Yue D; Zhang T; Qiao K; Wang Y; Zhao C; Lu J
J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933
[TBL] [Abstract][Full Text] [Related]
24. Statin resistance in Candida glabrata.
Subhan M; Faryal R; Macreadie I
Biotechnol Lett; 2018 Oct; 40(9-10):1389-1394. PubMed ID: 30054755
[TBL] [Abstract][Full Text] [Related]
25. HMGCR-associated myositis: a New Zealand case series and estimate of incidence.
Kennedy N; Keating P; O'Donnell J
Intern Med J; 2016 May; 46(5):622-5. PubMed ID: 27170241
[TBL] [Abstract][Full Text] [Related]
26. Clinico-serologic features of statin-induced necrotising autoimmune myopathy in a single-centre cohort.
Waters MJ; Limaye V
Clin Rheumatol; 2018 Feb; 37(2):543-547. PubMed ID: 28905130
[TBL] [Abstract][Full Text] [Related]
27. Statin use and breast cancer survival - a Swedish nationwide study.
Borgquist S; Broberg P; Tojjar J; Olsson H
BMC Cancer; 2019 Jan; 19(1):54. PubMed ID: 30634941
[TBL] [Abstract][Full Text] [Related]
28. The relationship between HMGCR genetic variation, alternative splicing, and statin efficacy.
Medina MW
Discov Med; 2010 Jun; 9(49):495-9. PubMed ID: 20587337
[TBL] [Abstract][Full Text] [Related]
29. Simvastatin is effective in killing the radioresistant breast carcinoma cells.
Aschenbrenner B; Negro G; Savic D; Sorokin M; Buzdin A; Ganswindt U; Cemazar M; Sersa G; Skvortsov S; Skvortsova I
Radiol Oncol; 2021 May; 55(3):305-316. PubMed ID: 33939900
[TBL] [Abstract][Full Text] [Related]
30. Clinical Characteristics of Anti-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Antibodies in Chinese Patients with Idiopathic Inflammatory Myopathies.
Ge Y; Lu X; Peng Q; Shu X; Wang G
PLoS One; 2015; 10(10):e0141616. PubMed ID: 26509687
[TBL] [Abstract][Full Text] [Related]
31. Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure.
Shovman O; Gilburd B; Chayat C; Lazar AD; Amital H; Blank M; Bentow C; Mahler M; Shoenfeld Y
Immunol Res; 2017 Feb; 65(1):276-281. PubMed ID: 27618830
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase increases the expression of interferon-responsive genes.
Yang X; Ouyang H; Chen F; Ma T; Dong M; Wang F; Pang D; Peng Z; Ren L
Clin Exp Pharmacol Physiol; 2014 Dec; 41(12):950-5. PubMed ID: 25115523
[TBL] [Abstract][Full Text] [Related]
33. Genetic variation in 3-hydroxy-3-methylglutaryl CoA reductase modifies the chemopreventive activity of statins for colorectal cancer.
Lipkin SM; Chao EC; Moreno V; Rozek LS; Rennert H; Pinchev M; Dizon D; Rennert G; Kopelovich L; Gruber SB
Cancer Prev Res (Phila); 2010 May; 3(5):597-603. PubMed ID: 20403997
[TBL] [Abstract][Full Text] [Related]
34. Statins in therapy: understanding their hydrophilicity, lipophilicity, binding to 3-hydroxy-3-methylglutaryl-CoA reductase, ability to cross the blood brain barrier and metabolic stability based on electrostatic molecular orbital studies.
Fong CW
Eur J Med Chem; 2014 Oct; 85():661-74. PubMed ID: 25128668
[TBL] [Abstract][Full Text] [Related]
35. HMG-CoA reductase expression in human eyelid tissue and in a human meibomian gland epithelial cell line.
Ooi KG; Rao A; Goh JS; Gracie G; Cherepanoff S; Madigan MC; Watson SL
Graefes Arch Clin Exp Ophthalmol; 2019 Apr; 257(4):785-790. PubMed ID: 30666404
[TBL] [Abstract][Full Text] [Related]
36. Explication of interactions between HMGCR isoform 2 and various statins through In silico modeling and docking.
Karthik MV; Satya Deepak MV; Shukla P
Comput Biol Med; 2012 Feb; 42(2):156-63. PubMed ID: 22177940
[TBL] [Abstract][Full Text] [Related]
37. [Dermatomyositis-like syndrome revealing statin-induced necrotizing autoimmune myopathy with anti-HMGCR antibodies].
Merlant M; Fite C; Kottler D; Maisonobe L; Dossier A; Deschamps L; Descamps V
Ann Dermatol Venereol; 2019 Sep; 146(8-9):550-556. PubMed ID: 30929872
[TBL] [Abstract][Full Text] [Related]
38. Pre-diagnostic statin use, lymph node status and mortality in women with stages I-III breast cancer.
Smith A; Murphy L; Zgaga L; Barron TI; Bennett K
Br J Cancer; 2017 Aug; 117(4):588-596. PubMed ID: 28720842
[TBL] [Abstract][Full Text] [Related]
39. Statin use and breast cancer: prospective results from the Women's Health Initiative.
Cauley JA; McTiernan A; Rodabough RJ; LaCroix A; Bauer DC; Margolis KL; Paskett ED; Vitolins MZ; Furberg CD; Chlebowski RT;
J Natl Cancer Inst; 2006 May; 98(10):700-7. PubMed ID: 16705124
[TBL] [Abstract][Full Text] [Related]
40. Statin-induced myalgia and myositis: an update on pathogenesis and clinical recommendations.
Selva-O'Callaghan A; Alvarado-Cardenas M; Pinal-Fernández I; Trallero-Araguás E; Milisenda JC; Martínez MÁ; Marín A; Labrador-Horrillo M; Juárez C; Grau-Junyent JM
Expert Rev Clin Immunol; 2018 Mar; 14(3):215-224. PubMed ID: 29473763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
